Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall J Bateman

Showing results (61-70 of 391) with videos related to

Pageof 40
Sort By:
JAMA Neurology|December 20, 2016
Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous SystemBrendan P Lucey, Kwasi G Mawuenyega, Bruce W Patterson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 17, 2021
Associations Between Physical Activity, Blood-Based Biomarkers of Neurodegeneration, and Cognition in Healthy Older Adults: The MAPT StudyJérémy Raffin, Yves Rolland, Geetika Aggarwal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2023
Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkersHaiyan Liu, Nicolas R Barthélemy, Vitaliy Ovod, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjectsKaushik Ghosal, Michael Haag, Philip B Verghese, et al.
Molecular Neurodegeneration|April 20, 2012
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labelingJacob M Basak, Jungsu Kim, Yuriy Pyatkivskyy, et al.
Journal of Neurochemistry|December 29, 2025
Post-Translational Modifications Distinguish Amyloid-β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's DiseaseSrinivas Koutarapu, Kaleigh F Roberts, Reid A Coyle, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are HyperphosphorylatedNicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
International Journal of Molecular Sciences|August 27, 2020
Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to PhenotypeHuifangjie Li, William C Knight, Pengfei Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseJohannes Levin, Jonathan Vöglein, Yakeel T Quiroz, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 13, 2020
Cross-Sectional and Longitudinal Associations Between Plasma Neurodegenerative Biomarkers and Physical Performance Among Community-Dwelling Older AdultsLingxiao He, Philipe de Souto Barreto, Kelly V Giudici, et al.
Pageof 40

Showing results (61-70 of 391) with videos related to

Sort By:
Pageof 40
JAMA Neurology|December 20, 2016
Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous SystemBrendan P Lucey, Kwasi G Mawuenyega, Bruce W Patterson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 17, 2021
Associations Between Physical Activity, Blood-Based Biomarkers of Neurodegeneration, and Cognition in Healthy Older Adults: The MAPT StudyJérémy Raffin, Yves Rolland, Geetika Aggarwal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 25, 2023
Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkersHaiyan Liu, Nicolas R Barthélemy, Vitaliy Ovod, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2017
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjectsKaushik Ghosal, Michael Haag, Philip B Verghese, et al.
Molecular Neurodegeneration|April 20, 2012
Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labelingJacob M Basak, Jungsu Kim, Yuriy Pyatkivskyy, et al.
Journal of Neurochemistry|December 29, 2025
Post-Translational Modifications Distinguish Amyloid-β Isoforms in Cerebral Amyloid Angiopathy and Alzheimer's DiseaseSrinivas Koutarapu, Kaleigh F Roberts, Reid A Coyle, et al.
Journal of Alzheimer'S Disease : JAD|November 22, 2021
Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are HyperphosphorylatedNicolas R Barthélemy, Balazs Toth, Paul T Manser, et al.
International Journal of Molecular Sciences|August 27, 2020
Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to PhenotypeHuifangjie Li, William C Knight, Pengfei Yang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseJohannes Levin, Jonathan Vöglein, Yakeel T Quiroz, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 13, 2020
Cross-Sectional and Longitudinal Associations Between Plasma Neurodegenerative Biomarkers and Physical Performance Among Community-Dwelling Older AdultsLingxiao He, Philipe de Souto Barreto, Kelly V Giudici, et al.
Pageof 40